Bulletin 01-21-01 Administration of SARS-CoV-2 Janssen Biotech Vaccine

The purpose of this bulletin is to inform Medical Assistance (MA) providers that the Department of Human Services (Department) added Current Procedural Terminology (CPT) code 0031A to the MA Program Fee Schedule for the administration of the novel coronavirus (SARS-CoV-2) vaccine manufactured by Janssen Biotech, Inc. in response to the coronavirus disease 2019 (COVID-19) pandemic.

Download PDF

 

Leave a comment